Imugene: A worldwide license to attack blood cancer
Listen to ASX-listed Imugene Managing Director Leslie Chong talk to Matt Birney on the Bulls N’ Bears Report about Imugene’s rapidly developing stable of extraordinary cancer fighting treatments that now take in blood cancers in addition to solid tumours.